FAT1‐mutated patients showed lower FAT1 mRNA expression rates than FAT1 wild‐type patients in the TCGA HNSCC cohort (P = 4.975e−05, Fig. S2A). The gene discussed is FAT1; the disease is head and neck squamous cell carcinoma.